دورية أكاديمية

LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206)

التفاصيل البيبلوغرافية
العنوان: LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206)
المؤلفون: Salazar, R., Tafuto, S., Krogh, M., Teule, A., Garcia-Carbonero, R., Klumpen, H.J., Cremer, B., Sevilla, I., Eriksson, B., Tabaksblat, E., Metges, J-P., Reed, N.S., Schrader, J., Navarro, V., Valentí, V., Hernando, J., Colao, A.M., Vestermark, L., Carnaghi, C., Capdevila, J.
المصدر: In Annals of Oncology September 2022 33 Supplement 7:S1412-S1412
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2022.08.044